

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 8.12113703 |
| 2 | negative thymic T cell selection (GO:0045060) | 7.94203001 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.53623832 |
| 4 | positive thymic T cell selection (GO:0045059) | 7.26907234 |
| 5 | regulation of isotype switching to IgG isotypes (GO:0048302) | 7.24973115 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.11304706 |
| 7 | positive T cell selection (GO:0043368) | 6.75135347 |
| 8 | thymic T cell selection (GO:0045061) | 6.74557834 |
| 9 | cytidine metabolic process (GO:0046087) | 6.71440587 |
| 10 | cytidine catabolic process (GO:0006216) | 6.71440587 |
| 11 | cytidine deamination (GO:0009972) | 6.71440587 |
| 12 | response to interleukin-15 (GO:0070672) | 6.63224463 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 6.59264179 |
| 14 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.55664214 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 6.42986844 |
| 16 | interferon-gamma production (GO:0032609) | 6.40614691 |
| 17 | T cell selection (GO:0045058) | 6.18290090 |
| 18 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.09769055 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.92523111 |
| 20 | regulation of T cell tolerance induction (GO:0002664) | 5.85234534 |
| 21 | negative regulation of cell killing (GO:0031342) | 5.73720985 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.73720985 |
| 23 | leukocyte aggregation (GO:0070486) | 5.67248969 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.58382509 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.58382509 |
| 26 | T cell receptor signaling pathway (GO:0050852) | 5.50631641 |
| 27 | T cell migration (GO:0072678) | 5.49959114 |
| 28 | T cell costimulation (GO:0031295) | 5.28078999 |
| 29 | lymphocyte costimulation (GO:0031294) | 5.22745233 |
| 30 | DNA deamination (GO:0045006) | 5.19020408 |
| 31 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 5.03303798 |
| 32 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.02770130 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.96341375 |
| 34 | tolerance induction (GO:0002507) | 4.93815485 |
| 35 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.87429825 |
| 36 | positive regulation of isotype switching (GO:0045830) | 4.86301591 |
| 37 | positive regulation of tolerance induction (GO:0002645) | 4.78716881 |
| 38 | activated T cell proliferation (GO:0050798) | 4.76090385 |
| 39 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.75431959 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.74991635 |
| 41 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.64802907 |
| 42 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.60511967 |
| 43 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.54857618 |
| 44 | regulation of regulatory T cell differentiation (GO:0045589) | 4.47596302 |
| 45 | regulation of isotype switching (GO:0045191) | 4.40447652 |
| 46 | positive regulation of interleukin-2 production (GO:0032743) | 4.38529023 |
| 47 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.37212179 |
| 48 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.31393427 |
| 49 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.31393427 |
| 50 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.31000117 |
| 51 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.31000117 |
| 52 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.24757518 |
| 53 | positive regulation of DNA recombination (GO:0045911) | 4.21246164 |
| 54 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.21029370 |
| 55 | regulation of tolerance induction (GO:0002643) | 4.20894998 |
| 56 | positive regulation of B cell mediated immunity (GO:0002714) | 4.18027059 |
| 57 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.18027059 |
| 58 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.05796084 |
| 59 | negative regulation by host of viral transcription (GO:0043922) | 4.03904634 |
| 60 | regulation of B cell mediated immunity (GO:0002712) | 3.92359105 |
| 61 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.92276169 |
| 62 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.85391640 |
| 63 | regulation of response to interferon-gamma (GO:0060330) | 3.83835524 |
| 64 | regulation of immunoglobulin production (GO:0002637) | 3.81503844 |
| 65 | positive regulation of immunoglobulin production (GO:0002639) | 3.80523017 |
| 66 | positive regulation of humoral immune response (GO:0002922) | 3.75141766 |
| 67 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.74961757 |
| 68 | T cell differentiation (GO:0030217) | 3.71295583 |
| 69 | mast cell activation (GO:0045576) | 3.64850781 |
| 70 | positive regulation of lymphocyte migration (GO:2000403) | 3.64452350 |
| 71 | alpha-beta T cell differentiation (GO:0046632) | 3.60331217 |
| 72 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.60287145 |
| 73 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.60065388 |
| 74 | regulation of activation of Janus kinase activity (GO:0010533) | 3.59389214 |
| 75 | cellular defense response (GO:0006968) | 3.54281838 |
| 76 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.53710108 |
| 77 | alpha-beta T cell activation (GO:0046631) | 3.53248476 |
| 78 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.52210106 |
| 79 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.52128230 |
| 80 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.51905086 |
| 81 | negative regulation of viral genome replication (GO:0045071) | 3.51140483 |
| 82 | NIK/NF-kappaB signaling (GO:0038061) | 3.48213846 |
| 83 | T cell activation (GO:0042110) | 3.46056053 |
| 84 | regulation of interleukin-2 production (GO:0032663) | 3.45230226 |
| 85 | negative regulation of T cell mediated immunity (GO:0002710) | 3.43959638 |
| 86 | negative regulation of T cell apoptotic process (GO:0070233) | 3.42960233 |
| 87 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.40765169 |
| 88 | positive regulation of cell killing (GO:0031343) | 3.40256688 |
| 89 | natural killer cell activation (GO:0030101) | 3.40204113 |
| 90 | sequestering of actin monomers (GO:0042989) | 3.38620826 |
| 91 | T cell homeostasis (GO:0043029) | 3.37433189 |
| 92 | granulocyte activation (GO:0036230) | 3.37118343 |
| 93 | positive regulation of granulocyte differentiation (GO:0030854) | 3.36461793 |
| 94 | positive regulation of T cell chemotaxis (GO:0010820) | 3.34546822 |
| 95 | regulation of T cell chemotaxis (GO:0010819) | 3.34546822 |
| 96 | leukocyte cell-cell adhesion (GO:0007159) | 3.34275270 |
| 97 | regulation of cell killing (GO:0031341) | 3.33275670 |
| 98 | myeloid dendritic cell differentiation (GO:0043011) | 3.32495281 |
| 99 | regulation of B cell differentiation (GO:0045577) | 3.31559425 |
| 100 | positive regulation of B cell differentiation (GO:0045579) | 3.30512939 |
| 101 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.28350256 |
| 102 | lymphocyte migration (GO:0072676) | 3.28253986 |
| 103 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.27217337 |
| 104 | Peyers patch development (GO:0048541) | 3.27217337 |
| 105 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.26680314 |
| 106 | positive regulation of interleukin-4 production (GO:0032753) | 3.26079335 |
| 107 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.23944199 |
| 108 | eosinophil chemotaxis (GO:0048245) | 3.21840196 |
| 109 | positive regulation of T cell activation (GO:0050870) | 3.21830389 |
| 110 | type I interferon signaling pathway (GO:0060337) | 3.20021473 |
| 111 | cellular response to type I interferon (GO:0071357) | 3.20021473 |
| 112 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.19917582 |
| 113 | positive regulation of defense response to virus by host (GO:0002230) | 3.18980450 |
| 114 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.18402484 |
| 115 | response to type I interferon (GO:0034340) | 3.16078914 |
| 116 | T cell differentiation involved in immune response (GO:0002292) | 3.15374584 |
| 117 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.15374584 |
| 118 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.15374584 |
| 119 | T-helper cell differentiation (GO:0042093) | 3.14798872 |
| 120 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.14798872 |
| 121 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.14494221 |
| 122 | myeloid dendritic cell activation (GO:0001773) | 3.13145137 |
| 123 | regulation of lymphocyte migration (GO:2000401) | 3.10414761 |
| 124 | regulation of defense response to virus by virus (GO:0050690) | 3.09412394 |
| 125 | regulation of chronic inflammatory response (GO:0002676) | 3.09037010 |
| 126 | regulation of interleukin-4 production (GO:0032673) | 3.08061664 |
| 127 | defense response to protozoan (GO:0042832) | 3.07769117 |
| 128 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.06540457 |
| 129 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.04282686 |
| 130 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.04259246 |
| 131 | positive regulation of T cell mediated immunity (GO:0002711) | 3.03686104 |
| 132 | positive regulation of T cell differentiation (GO:0045582) | 3.02592096 |
| 133 | T cell proliferation (GO:0042098) | 3.02327865 |
| 134 | regulation of alpha-beta T cell activation (GO:0046634) | 3.02250502 |
| 135 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.01563732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.84104104 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.28086408 |
| 3 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.90324190 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.82528857 |
| 5 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.73854716 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.73048163 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.65792406 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.55513244 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.54711483 |
| 10 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.52378474 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 3.36859120 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.35974963 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 3.01356739 |
| 14 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.00390185 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.85515385 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.85320950 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.77202088 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.69359202 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.48327298 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.43912752 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29224427 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23052951 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 2.21514852 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19652334 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.17481690 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.16900829 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.16249869 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.09011603 |
| 29 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.98592075 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97768598 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.89467164 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.85394303 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84572516 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.79791907 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77317304 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77224034 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75322696 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72863120 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68549916 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68279310 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67809294 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.65798368 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63280739 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.61438489 |
| 45 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.61392489 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56639706 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54830115 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54449265 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51067046 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46530724 |
| 51 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.45410713 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43918152 |
| 53 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43577702 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35794466 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34295347 |
| 56 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.33923095 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33662149 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33140521 |
| 59 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31307278 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25835357 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24080386 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18380151 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16604543 |
| 64 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13997373 |
| 65 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.12684481 |
| 66 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.11618882 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11138167 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10744694 |
| 69 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.09138151 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08919349 |
| 71 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06916658 |
| 72 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05387986 |
| 73 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04039251 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03517714 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98438898 |
| 76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98437278 |
| 77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96772747 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95828950 |
| 79 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94362459 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92774640 |
| 81 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92596044 |
| 82 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92164928 |
| 83 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92081891 |
| 84 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91459442 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90252211 |
| 86 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.87923588 |
| 87 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87606184 |
| 88 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87567805 |
| 89 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.86506221 |
| 90 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.86272844 |
| 91 | P300_27268052_Chip-Seq_Bcells_Human | 0.86132534 |
| 92 | GATA3_26560356_Chip-Seq_TH1_Human | 0.85547844 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85274478 |
| 94 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.83547824 |
| 95 | SA1_27219007_Chip-Seq_Bcells_Human | 0.82933304 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82803617 |
| 97 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.82406517 |
| 98 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.81352151 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.80885345 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80347386 |
| 101 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.80132265 |
| 102 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.78621848 |
| 103 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.77903612 |
| 104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77633608 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77630484 |
| 106 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77587532 |
| 107 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.76680598 |
| 108 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76133013 |
| 109 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.75721237 |
| 110 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74878081 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.73962200 |
| 112 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73090772 |
| 113 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.70810300 |
| 114 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.69850483 |
| 115 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69610297 |
| 116 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.67666173 |
| 117 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.66426506 |
| 118 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.64983039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 5.94878252 |
| 2 | MP0005671_abnormal_response_to | 5.06856303 |
| 3 | MP0000685_abnormal_immune_system | 3.67944722 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.39075126 |
| 5 | MP0001800_abnormal_humoral_immune | 3.35336668 |
| 6 | MP0001790_abnormal_immune_system | 3.14356766 |
| 7 | MP0005387_immune_system_phenotype | 3.14356766 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.09231590 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.96743854 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.94799227 |
| 11 | MP0006082_CNS_inflammation | 2.87123818 |
| 12 | * MP0002420_abnormal_adaptive_immunity | 2.85223512 |
| 13 | * MP0002398_abnormal_bone_marrow | 2.84990453 |
| 14 | MP0009785_altered_susceptibility_to | 2.84770215 |
| 15 | * MP0002723_abnormal_immune_serum | 2.83912315 |
| 16 | MP0002405_respiratory_system_inflammati | 2.81935829 |
| 17 | * MP0001819_abnormal_immune_cell | 2.80652375 |
| 18 | MP0000703_abnormal_thymus_morphology | 2.78832907 |
| 19 | MP0003436_decreased_susceptibility_to | 2.73978553 |
| 20 | MP0001873_stomach_inflammation | 2.65762922 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.62054131 |
| 22 | MP0005025_abnormal_response_to | 2.47414263 |
| 23 | * MP0000716_abnormal_immune_system | 2.46052675 |
| 24 | MP0002006_tumorigenesis | 2.45998506 |
| 25 | MP0003724_increased_susceptibility_to | 2.41878592 |
| 26 | MP0002722_abnormal_immune_system | 2.36170803 |
| 27 | MP0002933_joint_inflammation | 2.33425721 |
| 28 | MP0003866_abnormal_defecation | 2.33208860 |
| 29 | MP0003300_gastrointestinal_ulcer | 2.29053632 |
| 30 | MP0002396_abnormal_hematopoietic_system | 2.25625380 |
| 31 | MP0000689_abnormal_spleen_morphology | 2.25053541 |
| 32 | MP0010155_abnormal_intestine_physiology | 2.24112041 |
| 33 | MP0004510_myositis | 2.15460222 |
| 34 | MP0004947_skin_inflammation | 2.14118696 |
| 35 | * MP0002429_abnormal_blood_cell | 1.99279350 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.89332630 |
| 37 | MP0003303_peritoneal_inflammation | 1.81096562 |
| 38 | MP0001853_heart_inflammation | 1.75233989 |
| 39 | MP0002419_abnormal_innate_immunity | 1.71860871 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.71828831 |
| 41 | MP0005310_abnormal_salivary_gland | 1.58633930 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.51210217 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.47504402 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.45400670 |
| 45 | MP0000858_altered_metastatic_potential | 1.45397847 |
| 46 | MP0004381_abnormal_hair_follicle | 1.37841858 |
| 47 | MP0002132_abnormal_respiratory_system | 1.26771018 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.23154398 |
| 49 | MP0003448_altered_tumor_morphology | 1.19101583 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.17878880 |
| 51 | MP0000490_abnormal_crypts_of | 1.15267783 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.13735253 |
| 53 | MP0001851_eye_inflammation | 1.12793789 |
| 54 | MP0005451_abnormal_body_composition | 1.09400764 |
| 55 | MP0008057_abnormal_DNA_replication | 1.08975482 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.08123543 |
| 57 | MP0002163_abnormal_gland_morphology | 1.05504593 |
| 58 | MP0008469_abnormal_protein_level | 1.04679953 |
| 59 | MP0003786_premature_aging | 0.97546064 |
| 60 | MP0005075_abnormal_melanosome_morpholog | 0.97169202 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 0.96268011 |
| 62 | MP0002998_abnormal_bone_remodeling | 0.94116583 |
| 63 | MP0008961_abnormal_basal_metabolism | 0.91023572 |
| 64 | MP0002009_preneoplasia | 0.87961277 |
| 65 | MP0003077_abnormal_cell_cycle | 0.75479922 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 0.74128898 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 0.73906572 |
| 68 | MP0001545_abnormal_hematopoietic_system | 0.73906572 |
| 69 | MP0001919_abnormal_reproductive_system | 0.73216408 |
| 70 | MP0005023_abnormal_wound_healing | 0.67164593 |
| 71 | MP0000372_irregular_coat_pigmentation | 0.66997803 |
| 72 | MP0009763_increased_sensitivity_to | 0.66867107 |
| 73 | MP0003045_fibrosis | 0.66361185 |
| 74 | MP0008873_increased_physiological_sensi | 0.65201759 |
| 75 | MP0003693_abnormal_embryo_hatching | 0.65025056 |
| 76 | MP0001727_abnormal_embryo_implantation | 0.63724859 |
| 77 | MP0005076_abnormal_cell_differentiation | 0.63444648 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.60552138 |
| 79 | MP0004957_abnormal_blastocyst_morpholog | 0.59680012 |
| 80 | MP0001243_abnormal_dermal_layer | 0.58797107 |
| 81 | MP0003795_abnormal_bone_structure | 0.57987878 |
| 82 | MP0000604_amyloidosis | 0.57933859 |
| 83 | MP0010094_abnormal_chromosome_stability | 0.57901276 |
| 84 | MP0001663_abnormal_digestive_system | 0.57019002 |
| 85 | MP0000477_abnormal_intestine_morphology | 0.55762398 |
| 86 | MP0000609_abnormal_liver_physiology | 0.55246315 |
| 87 | MP0010307_abnormal_tumor_latency | 0.53549767 |
| 88 | MP0008007_abnormal_cellular_replicative | 0.53055106 |
| 89 | MP0001348_abnormal_lacrimal_gland | 0.52984116 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.49834583 |
| 91 | MP0001881_abnormal_mammary_gland | 0.49458468 |
| 92 | MP0009764_decreased_sensitivity_to | 0.49367564 |
| 93 | MP0005390_skeleton_phenotype | 0.48359270 |
| 94 | MP0005166_decreased_susceptibility_to | 0.47837053 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.46492167 |
| 96 | MP0002822_catalepsy | 0.46474871 |
| 97 | MP0000313_abnormal_cell_death | 0.45544421 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.44563629 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.44222051 |
| 100 | MP0000015_abnormal_ear_pigmentation | 0.43601673 |
| 101 | MP0001191_abnormal_skin_condition | 0.43024933 |
| 102 | MP0008058_abnormal_DNA_repair | 0.42000806 |
| 103 | MP0009278_abnormal_bone_marrow | 0.41645217 |
| 104 | MP0003453_abnormal_keratinocyte_physiol | 0.40882372 |
| 105 | MP0003959_abnormal_lean_body | 0.40081918 |
| 106 | MP0001216_abnormal_epidermal_layer | 0.39818735 |
| 107 | MP0003172_abnormal_lysosome_physiology | 0.38710325 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.38623493 |
| 109 | MP0000249_abnormal_blood_vessel | 0.38312827 |
| 110 | MP0000367_abnormal_coat/_hair | 0.37427148 |
| 111 | MP0002095_abnormal_skin_pigmentation | 0.37330776 |
| 112 | MP0003111_abnormal_nucleus_morphology | 0.37160065 |
| 113 | MP0001765_abnormal_ion_homeostasis | 0.36589764 |
| 114 | MP0000920_abnormal_myelination | 0.36472347 |
| 115 | MP0005381_digestive/alimentary_phenotyp | 0.35610750 |
| 116 | MP0002083_premature_death | 0.35448739 |
| 117 | MP0002254_reproductive_system_inflammat | 0.34178231 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.34017167 |
| 119 | MP0006035_abnormal_mitochondrial_morpho | 0.32216095 |
| 120 | MP0005379_endocrine/exocrine_gland_phen | 0.32196461 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.31185963 |
| 122 | MP0001502_abnormal_circadian_rhythm | 0.30947192 |
| 123 | MP0001661_extended_life_span | 0.30764662 |
| 124 | MP0005319_abnormal_enzyme/_coenzyme | 0.29876173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.68534112 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.38299495 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 6.69385460 |
| 4 | Combined immunodeficiency (HP:0005387) | 6.12983226 |
| 5 | Stomatitis (HP:0010280) | 6.09922748 |
| 6 | Abnormality of T cells (HP:0002843) | 5.66269574 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.46868479 |
| 8 | Panhypogammaglobulinemia (HP:0003139) | 5.19920868 |
| 9 | Recurrent bronchitis (HP:0002837) | 5.18830465 |
| 10 | IgG deficiency (HP:0004315) | 4.87344502 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.78720555 |
| 12 | IgM deficiency (HP:0002850) | 4.71319020 |
| 13 | Eczematoid dermatitis (HP:0000976) | 4.69051385 |
| 14 | Nasal polyposis (HP:0100582) | 4.61034398 |
| 15 | B lymphocytopenia (HP:0010976) | 4.39730971 |
| 16 | Abnormality of B cell number (HP:0010975) | 4.39730971 |
| 17 | Chronic diarrhea (HP:0002028) | 4.30531735 |
| 18 | Increased IgM level (HP:0003496) | 4.25152381 |
| 19 | Recurrent viral infections (HP:0004429) | 4.14673029 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.11478969 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 4.11478969 |
| 22 | Myositis (HP:0100614) | 3.90964363 |
| 23 | Chronic otitis media (HP:0000389) | 3.90060105 |
| 24 | Abnormality of eosinophils (HP:0001879) | 3.86662349 |
| 25 | Abnormality of T cell physiology (HP:0011840) | 3.85766502 |
| 26 | Thyroiditis (HP:0100646) | 3.80840661 |
| 27 | Autoimmune hemolytic anemia (HP:0001890) | 3.78235459 |
| 28 | Abnormality of the nasal mucosa (HP:0000433) | 3.75321806 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 3.73053053 |
| 30 | Lymphopenia (HP:0001888) | 3.71541187 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.65896139 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.64764267 |
| 33 | Joint swelling (HP:0001386) | 3.61049250 |
| 34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.60509544 |
| 35 | Pustule (HP:0200039) | 3.58873425 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 3.51427974 |
| 37 | Eosinophilia (HP:0001880) | 3.49009557 |
| 38 | Leukocytosis (HP:0001974) | 3.42215267 |
| 39 | Abnormality of the fingertips (HP:0001211) | 3.41978665 |
| 40 | IgA deficiency (HP:0002720) | 3.26750188 |
| 41 | Hypoplasia of the thymus (HP:0000778) | 3.23207418 |
| 42 | Recurrent sinusitis (HP:0011108) | 3.13457419 |
| 43 | Optic neuritis (HP:0100653) | 3.09518624 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 3.09518624 |
| 45 | Meningitis (HP:0001287) | 3.06097207 |
| 46 | Vasculitis (HP:0002633) | 3.02581428 |
| 47 | Granulocytopenia (HP:0001913) | 2.99158760 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.96649296 |
| 49 | Lymphoma (HP:0002665) | 2.93608788 |
| 50 | Hemoptysis (HP:0002105) | 2.93087439 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.91915888 |
| 52 | Bronchitis (HP:0012387) | 2.91553542 |
| 53 | Hypoproteinemia (HP:0003075) | 2.80883746 |
| 54 | Orchitis (HP:0100796) | 2.76568457 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70710021 |
| 56 | Obstructive lung disease (HP:0006536) | 2.70710021 |
| 57 | Hypergammaglobulinemia (HP:0010702) | 2.65728358 |
| 58 | Encephalitis (HP:0002383) | 2.58421563 |
| 59 | Inflammation of the large intestine (HP:0002037) | 2.52919993 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.52314670 |
| 61 | Aplastic anemia (HP:0001915) | 2.51423625 |
| 62 | Arterial thrombosis (HP:0004420) | 2.51355563 |
| 63 | Hypochromic anemia (HP:0001931) | 2.50322181 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.48999651 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.48691981 |
| 66 | Recurrent skin infections (HP:0001581) | 2.48423627 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 2.45109607 |
| 68 | Chest pain (HP:0100749) | 2.43560281 |
| 69 | Increased IgE level (HP:0003212) | 2.40506647 |
| 70 | Basal cell carcinoma (HP:0002671) | 2.39351301 |
| 71 | Abnormality of the prostate (HP:0008775) | 2.38892761 |
| 72 | Increased density of long bones (HP:0006392) | 2.38840944 |
| 73 | Ureteral stenosis (HP:0000071) | 2.34201896 |
| 74 | Recurrent otitis media (HP:0000403) | 2.32683486 |
| 75 | Thrombocytosis (HP:0001894) | 2.27199964 |
| 76 | Keratitis (HP:0000491) | 2.27071556 |
| 77 | Spontaneous hematomas (HP:0007420) | 2.26412048 |
| 78 | Acute hepatic failure (HP:0006554) | 2.25331881 |
| 79 | Amaurosis fugax (HP:0100576) | 2.21789867 |
| 80 | Urticaria (HP:0001025) | 2.16979209 |
| 81 | Cheilitis (HP:0100825) | 2.16779621 |
| 82 | Keratoconjunctivitis sicca (HP:0001097) | 2.16080569 |
| 83 | Hemiplegia (HP:0002301) | 2.13785200 |
| 84 | Ureteral obstruction (HP:0006000) | 2.12123745 |
| 85 | Pulmonary embolism (HP:0002204) | 2.10234864 |
| 86 | Chronic sinusitis (HP:0011109) | 2.09944387 |
| 87 | Gastrointestinal stroma tumor (HP:0100723) | 2.07360311 |
| 88 | Epistaxis (HP:0000421) | 2.06030647 |
| 89 | Papilloma (HP:0012740) | 2.05655682 |
| 90 | Verrucae (HP:0200043) | 2.05655682 |
| 91 | Glomerulopathy (HP:0100820) | 2.02730371 |
| 92 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.00798460 |
| 93 | Skin rash (HP:0000988) | 2.00749822 |
| 94 | Bronchiectasis (HP:0002110) | 2.00511685 |
| 95 | Gangrene (HP:0100758) | 1.96977533 |
| 96 | Colitis (HP:0002583) | 1.96807001 |
| 97 | Increased serum ferritin (HP:0003281) | 1.95141912 |
| 98 | Emphysema (HP:0002097) | 1.93310699 |
| 99 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93147597 |
| 100 | Keratoconjunctivitis (HP:0001096) | 1.93026810 |
| 101 | Hepatitis (HP:0012115) | 1.91861469 |
| 102 | Gingivitis (HP:0000230) | 1.91333402 |
| 103 | Premature loss of primary teeth (HP:0006323) | 1.91125952 |
| 104 | Episodic fever (HP:0001954) | 1.90810263 |
| 105 | Anorexia (HP:0002039) | 1.88812337 |
| 106 | Abnormality of the pericardium (HP:0001697) | 1.82714922 |
| 107 | Diplopia (HP:0000651) | 1.82699089 |
| 108 | Abnormality of binocular vision (HP:0011514) | 1.82699089 |
| 109 | Polyneuropathy (HP:0001271) | 1.81856087 |
| 110 | Hepatosplenomegaly (HP:0001433) | 1.81496086 |
| 111 | Arthralgia (HP:0002829) | 1.81164915 |
| 112 | Gingival bleeding (HP:0000225) | 1.79069834 |
| 113 | Pulmonary fibrosis (HP:0002206) | 1.77993407 |
| 114 | Prolonged bleeding time (HP:0003010) | 1.77962469 |
| 115 | Amyotrophic lateral sclerosis (HP:0007354) | 1.77068943 |
| 116 | Persistence of primary teeth (HP:0006335) | 1.74943513 |
| 117 | Seborrheic dermatitis (HP:0001051) | 1.74628133 |
| 118 | Skin ulcer (HP:0200042) | 1.74314243 |
| 119 | Abnormal platelet volume (HP:0011876) | 1.71145364 |
| 120 | Abnormality of the pleura (HP:0002103) | 1.69980829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.85800395 |
| 2 | MAP4K1 | 6.39100037 |
| 3 | ZAP70 | 3.83778004 |
| 4 | ITK | 3.29849397 |
| 5 | JAK3 | 3.25223171 |
| 6 | RIPK4 | 2.87140563 |
| 7 | FGFR4 | 2.56518366 |
| 8 | IKBKE | 2.34458634 |
| 9 | STK10 | 2.26216151 |
| 10 | MAP3K14 | 2.21140946 |
| 11 | KDR | 2.20192896 |
| 12 | TYK2 | 2.15954261 |
| 13 | TESK2 | 2.07702624 |
| 14 | GRK6 | 1.99724789 |
| 15 | JAK1 | 1.95823580 |
| 16 | * LCK | 1.89593634 |
| 17 | NLK | 1.80105883 |
| 18 | FGFR3 | 1.62785871 |
| 19 | CSK | 1.61911601 |
| 20 | EEF2K | 1.61814442 |
| 21 | TEC | 1.60704547 |
| 22 | PRPF4B | 1.53567943 |
| 23 | SYK | 1.52812856 |
| 24 | TAOK3 | 1.48252120 |
| 25 | TBK1 | 1.47199792 |
| 26 | MST4 | 1.46431028 |
| 27 | MAP3K10 | 1.40775095 |
| 28 | HCK | 1.33817338 |
| 29 | IKBKB | 1.31470040 |
| 30 | BTK | 1.29931364 |
| 31 | BLK | 1.24043805 |
| 32 | CHUK | 1.19650765 |
| 33 | PRKCQ | 1.17060586 |
| 34 | PRKCH | 1.14556555 |
| 35 | SIK3 | 1.12689533 |
| 36 | TLK1 | 1.06606514 |
| 37 | NME2 | 1.06309036 |
| 38 | CDK12 | 1.04435245 |
| 39 | RPS6KA4 | 1.01951225 |
| 40 | MATK | 1.00552241 |
| 41 | GRK7 | 0.98086845 |
| 42 | SIK2 | 0.95914939 |
| 43 | PIM1 | 0.95443420 |
| 44 | MAP3K12 | 0.89755458 |
| 45 | CAMKK2 | 0.89388199 |
| 46 | MARK3 | 0.88804837 |
| 47 | CLK1 | 0.87892592 |
| 48 | TSSK6 | 0.86174970 |
| 49 | LYN | 0.84008655 |
| 50 | MAP3K7 | 0.81541428 |
| 51 | MAP3K1 | 0.79629380 |
| 52 | EPHA3 | 0.79250019 |
| 53 | IRAK4 | 0.78982568 |
| 54 | TNK2 | 0.77859118 |
| 55 | NME1 | 0.76823387 |
| 56 | TAOK1 | 0.75447476 |
| 57 | LRRK2 | 0.75352911 |
| 58 | MAP3K13 | 0.74780952 |
| 59 | JAK2 | 0.73144561 |
| 60 | MAP3K11 | 0.73113803 |
| 61 | EPHB1 | 0.71425140 |
| 62 | SMG1 | 0.71094634 |
| 63 | TRIB3 | 0.70662530 |
| 64 | MAPK12 | 0.69134077 |
| 65 | KIT | 0.67808646 |
| 66 | TGFBR2 | 0.66625352 |
| 67 | FES | 0.65574061 |
| 68 | BMPR2 | 0.65566301 |
| 69 | BUB1 | 0.61145416 |
| 70 | PDGFRB | 0.59789497 |
| 71 | TESK1 | 0.59742175 |
| 72 | BCKDK | 0.59261705 |
| 73 | MAPKAPK3 | 0.55440256 |
| 74 | CAMKK1 | 0.54399172 |
| 75 | SRPK1 | 0.52795881 |
| 76 | BRD4 | 0.52639228 |
| 77 | CDK4 | 0.52436964 |
| 78 | INSR | 0.52171733 |
| 79 | PIM2 | 0.52007783 |
| 80 | TYRO3 | 0.51235708 |
| 81 | MAP2K3 | 0.50936355 |
| 82 | SCYL2 | 0.49884509 |
| 83 | ALK | 0.49538349 |
| 84 | MAP3K3 | 0.48930082 |
| 85 | SIK1 | 0.48515217 |
| 86 | MARK2 | 0.46965882 |
| 87 | CSF1R | 0.46771078 |
| 88 | PKN2 | 0.46593721 |
| 89 | RPS6KA5 | 0.45545906 |
| 90 | DAPK2 | 0.45522868 |
| 91 | FYN | 0.45135219 |
| 92 | PASK | 0.44355712 |
| 93 | ADRBK2 | 0.40590943 |
| 94 | IRAK1 | 0.39189386 |
| 95 | MELK | 0.38044010 |
| 96 | IGF1R | 0.36792544 |
| 97 | PDK1 | 0.36686019 |
| 98 | HIPK2 | 0.35862019 |
| 99 | CDK9 | 0.33051997 |
| 100 | CDC7 | 0.32709424 |
| 101 | MAP2K6 | 0.31401816 |
| 102 | EIF2AK1 | 0.30144117 |
| 103 | MAP3K8 | 0.28639459 |
| 104 | RAF1 | 0.28552494 |
| 105 | PRKD2 | 0.27744250 |
| 106 | MAPK7 | 0.27400481 |
| 107 | DMPK | 0.26602865 |
| 108 | TAOK2 | 0.26045124 |
| 109 | RPS6KA1 | 0.24905018 |
| 110 | PRKCD | 0.24672450 |
| 111 | EIF2AK3 | 0.24084206 |
| 112 | MAPK3 | 0.23952408 |
| 113 | WNK4 | 0.23886595 |
| 114 | STK24 | 0.23077898 |
| 115 | MAPKAPK2 | 0.22635180 |
| 116 | ERN1 | 0.22597172 |
| 117 | MAPK11 | 0.22550273 |
| 118 | PIK3CG | 0.21355226 |
| 119 | ABL1 | 0.21270698 |
| 120 | IRAK3 | 0.20005800 |
| 121 | ROCK2 | 0.19287366 |
| 122 | ATR | 0.18713320 |
| 123 | PIK3CA | 0.17493762 |
| 124 | STK4 | 0.17441244 |
| 125 | TGFBR1 | 0.17403058 |
| 126 | NEK2 | 0.16378035 |
| 127 | EGFR | 0.14778264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.75224478 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.06202956 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.56927637 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.47182574 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.44507788 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.16700526 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.94288350 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.82203404 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.70808378 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.56942512 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.50935846 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.18187283 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.93803355 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.91206986 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.84272809 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79699820 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.74089009 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.67591477 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60853126 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50577322 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47134110 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46753880 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30032400 |
| 24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29365980 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27824362 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22578166 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22439200 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21592430 |
| 29 | HTLV-I infection_Homo sapiens_hsa05166 | 1.19387195 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.16567764 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.15411613 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.15056293 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10380021 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10081987 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06325137 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05527065 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02934437 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.01689090 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00649600 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 0.99859685 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 0.94570049 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94268148 |
| 43 | Spliceosome_Homo sapiens_hsa03040 | 0.92698293 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90894253 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85261584 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84835913 |
| 47 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.84778761 |
| 48 | Malaria_Homo sapiens_hsa05144 | 0.83274725 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82398143 |
| 50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80245778 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79110643 |
| 52 | Ribosome_Homo sapiens_hsa03010 | 0.77313232 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76838290 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74646055 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.69321419 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68466575 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68171342 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66853971 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66784052 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.65547386 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.65140244 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64601487 |
| 63 | RNA degradation_Homo sapiens_hsa03018 | 0.63977278 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.62040103 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61782207 |
| 66 | DNA replication_Homo sapiens_hsa03030 | 0.60176061 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.58163421 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55706393 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.54412705 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.51804176 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.51204481 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47198606 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.45004112 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44306851 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43889170 |
| 76 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.43543003 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42029999 |
| 78 | RNA transport_Homo sapiens_hsa03013 | 0.40855028 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40318498 |
| 80 | Mismatch repair_Homo sapiens_hsa03430 | 0.39774719 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39443686 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.39433720 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39320093 |
| 84 | Proteasome_Homo sapiens_hsa03050 | 0.38980855 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35951954 |
| 86 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.32132111 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30220880 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29937737 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29111956 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28652714 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28226170 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27248313 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26689015 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.26022547 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24997510 |
| 96 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.24885368 |
| 97 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24373204 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23843858 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.23701122 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23550716 |
| 101 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.23050440 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22847636 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.22083357 |
| 104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.21810933 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.21405741 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21333507 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21264905 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20938644 |
| 109 | Homologous recombination_Homo sapiens_hsa03440 | 0.20506585 |
| 110 | Adherens junction_Homo sapiens_hsa04520 | 0.19613490 |
| 111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.18453282 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.17472720 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.17306787 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.17248527 |
| 115 | RNA polymerase_Homo sapiens_hsa03020 | 0.16661401 |
| 116 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.15809105 |
| 117 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.14052301 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11206004 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.09819964 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.07149519 |

